Pfizer (PFE) Receives Positive CHMP Opinion for Oncology Biosimilar, ZIRABEV

December 14, 2018 10:29 AM
Pfizer Inc. (NYSE: PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles